Kenan Onel

7.0k total citations · 1 hit paper
78 papers, 3.1k citations indexed

About

Kenan Onel is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Kenan Onel has authored 78 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 21 papers in Hematology and 21 papers in Cancer Research. Recurrent topics in Kenan Onel's work include Cancer Genomics and Diagnostics (15 papers), Acute Lymphoblastic Leukemia research (14 papers) and DNA Repair Mechanisms (11 papers). Kenan Onel is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Acute Lymphoblastic Leukemia research (14 papers) and DNA Repair Mechanisms (11 papers). Kenan Onel collaborates with scholars based in United States, United Kingdom and Canada. Kenan Onel's co-authors include Carlos Cordon‐Cardo, Louise C. Strong, Elisabeth E. Bond, Gareth L. Bond, Jill Bargonetti, Harlan Robins, Helge Täubert, Peter Wuerl, Guillermina Lozano and Arnold J. Levine and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Kenan Onel

74 papers receiving 3.0k citations

Hit Papers

A Single Nucleotide Polym... 2004 2026 2011 2018 2004 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kenan Onel 1.6k 1.5k 567 408 379 78 3.1k
Allen Buxton 1.0k 0.6× 977 0.6× 528 0.9× 276 0.7× 211 0.6× 49 3.1k
He-Jing Wang 1.3k 0.8× 2.6k 1.7× 791 1.4× 332 0.8× 255 0.7× 36 4.4k
Howard M. Katzenstein 1.2k 0.8× 978 0.6× 707 1.2× 129 0.3× 267 0.7× 111 3.5k
Justin Kline 1.2k 0.7× 2.8k 1.8× 247 0.4× 938 2.3× 220 0.6× 146 5.5k
John C. Krauss 839 0.5× 1.3k 0.9× 292 0.5× 143 0.4× 421 1.1× 137 3.0k
Kristy L. Richards 1.3k 0.8× 760 0.5× 324 0.6× 323 0.8× 240 0.6× 86 2.9k
John Ellerton 1.2k 0.7× 1.4k 0.9× 388 0.7× 1.4k 3.3× 174 0.5× 29 3.3k
Meredith A. Goldwasser 875 0.5× 1.4k 0.9× 342 0.6× 218 0.5× 100 0.3× 29 2.7k
Patricia Pautier 1.6k 1.0× 1.8k 1.2× 600 1.1× 108 0.3× 175 0.5× 200 4.8k
R. Erttmann 631 0.4× 858 0.6× 315 0.6× 492 1.2× 141 0.4× 83 2.6k

Countries citing papers authored by Kenan Onel

Since Specialization
Citations

This map shows the geographic impact of Kenan Onel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenan Onel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenan Onel more than expected).

Fields of papers citing papers by Kenan Onel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenan Onel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenan Onel. The network helps show where Kenan Onel may publish in the future.

Co-authorship network of co-authors of Kenan Onel

This figure shows the co-authorship network connecting the top 25 collaborators of Kenan Onel. A scholar is included among the top collaborators of Kenan Onel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenan Onel. Kenan Onel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brock, Pamela, M. N. Webster, Sandya Liyanarachchi, et al.. (2025). Germline POT1 Variants in a Pan-Cancer Cohort. JCO Precision Oncology. 9(9). e2400946–e2400946.
2.
Gruber, Dorota, et al.. (2025). The Diagnostic Yield of Panel Versus Exome Sequencing to Identify Hereditary Cancer Disorders in Pediatric Cancer. Journal of Pediatric Hematology/Oncology. 47(2). 74–79.
3.
Gold, Julie, Alessandro Laganà, Kenan Onel, et al.. (2024). FaMMily Affairs: Dissecting inherited contributions to multiple myeloma risk. Seminars in Hematology. 62(1). 11–19. 1 indexed citations
4.
Bao, Riyue, Mark M. Sasaki, Myvizhi Esai Selvan, et al.. (2021). Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility. Cancer Prevention Research. 14(4). 441–454. 2 indexed citations
5.
Khoei, Nazlisadat Seyed, Robert Carreras‐Torres, Neil Murphy, et al.. (2021). Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells. 10(2). 394–394. 22 indexed citations
6.
Tegay, David, et al.. (2019). Precision oncology: lessons learned and challenges for the future. SHILAP Revista de lepidopterología.
7.
Yang, Hsih‐Te, Ronak Shah, David Tegay, & Kenan Onel. (2019). <p>Precision oncology: lessons learned and challenges for the future</p>. Cancer Management and Research. Volume 11. 7525–7536. 9 indexed citations
9.
Sasaki, Mark M., Andrew D. Skol, Riyue Bao, et al.. (2015). Integrated Genomic Analysis Suggests MLL3 Is a Novel Candidate Susceptibility Gene for Familial Nasopharyngeal Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1222–1228. 11 indexed citations
10.
Hahn, Theresa, Lara E. Sucheston‐Campbell, Leah Preus, et al.. (2015). Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(9). 1679–1686. 16 indexed citations
11.
Keegan, Theresa H.M., Raymon H. Grogan, Helen Parsons, et al.. (2015). Sociodemographic Disparities in Differentiated Thyroid Cancer Survival Among Adolescents and Young Adults in California. Thyroid. 25(6). 635–648. 54 indexed citations
12.
Goss, Kathleen H., et al.. (2015). The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(3). 711–723. 20 indexed citations
13.
Voce, David J., Anja Schmitt, Abhineet Uppal, et al.. (2014). Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor. Oncogene. 34(21). 2807–2813. 23 indexed citations
14.
Godley, Lucy A., John M. Cunningham, M. Eileen Dolan, et al.. (2011). An Integrated Genomic Approach to the Assessment and Treatment of Acute Myeloid Leukemia. Seminars in Oncology. 38(2). 215–224. 15 indexed citations
15.
Tan, Yi‐Hung Carol, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.. (2010). CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases. PLoS ONE. 5(1). e8972–e8972. 84 indexed citations
16.
Churpek, Jane E. & Kenan Onel. (2010). Heritability of Hematologic Malignancies: From Pedigrees to Genomics. Hematology/Oncology Clinics of North America. 24(5). 939–972. 6 indexed citations
17.
Woo, Leslie L., Kenan Onel, & Nathan A. Ellis. (2007). The broken genome: Genetic and pharmacologic approaches to breaking DNA. Annals of Medicine. 39(3). 208–218. 4 indexed citations
18.
Kropp, Silke, Irmgard Helmbold, Peter Schmezer, et al.. (2007). Genetic predictors of long‐term toxicities after radiation therapy for breast cancer. International Journal of Cancer. 122(6). 1333–1339. 42 indexed citations
19.
Onel, Kenan & Carlos Cordon‐Cardo. (2004). MDM2 and Prognosis. Molecular Cancer Research. 2(1). 1–8. 158 indexed citations
20.
Bond, Gareth L., Wenwei Hu, Elisabeth E. Bond, et al.. (2004). A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans. Cell. 119(5). 591–602. 1026 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026